Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents

Kyoung Ha Kim(Soonchunhyang University Hospital Seoul), Jong-Ho Won(Soonchunhyang University Hospital Seoul)
Anticancer Research
December 27, 2018
10.21873/anticanres.13088
Cited by 3

Related Papers

No related papers found

Powered by citation graph analysis